Dihexa
Preclinical angiotensin-derived nootropic — synaptogenesis research. Essentially no human data.
- Half-life
- Not established
- Out of system
- —
- Route
- Oral
- Level
- Advanced
What Dihexa is used for
- Extremely potent synaptogenesis in preclinical (animal) models
- Studied for memory and neurodegeneration research
How it's typically used
No established human protocol. Reported research range: 5–8 mg oral daily.
What to watch for
- Essentially zero human safety or efficacy data
- Promoting nerve growth has unknown long-term (including tumor) implications
- Not approved for human use; purity and dosing are unverified
About Other research compounds
- What they are
- Nootropics, metabolic agents, and research compounds that don't fit the other classes.
- How they're run
- Route and schedule vary widely — check the individual entry.
- What to watch
- This is the least-characterised corner of the atlas. Read the full guide, and treat anything without published human data as exactly that.
Full guide
Dihexa: A Tracking Guide for a Preclinical Nootropic
A measured look at Dihexa, why almost all of the evidence is in animals, and what a careful self-experimenter would actually log.
Other other research compounds
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.